Eric: Thank you so much for your time today and really excited to learn more about this and also, you know, get, be able to give, you know, folks whove been struggling maybe with a chronic sprain or strain, a way to get back to their active lifestyle
Isoprenoid pathway dysfunction in chronic fatigue syndrome
By amplifying innate repair pathways, it becomes a practical tool in personalized approaches to injury recovery and chronic pain management
10.1016/j.molcel.2019.10.028 Mol
Mechanism: AOD 9604 stimulates lipolysis and inhibits lipogenesis in fat cells via beta-3 adrenergic receptors
Here is what the current body of research (which is predominantly animal studies) suggests BPC-157 does: Promotes angiogenesis: It appears to upregulate VEGF (vascular endothelial growth factor) signaling, stimulating the growth of new blood vessels into damaged tissue